Actos 'Most Substantial' Factor In Man's Cancer, Doc Testifies

By Ciaran McEvoy (March 26, 2013, 3:33 PM EDT) -- Takeda Pharmaceutical Co.'s diabetes drug Actos was "the most substantial causative factor" in a California man's terminal bladder cancer, a urologist testifying for the plaintiff told a Los Angeles jury Tuesday in the first product liability trial of its kind....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!